microRNA-210 in red blood cells differentially regulates vascular endothelial function between type 1 and type 2...

Area of Science:

• Cardiovascular Biology
• Endocrinology
• Molecular Medicine

Background:

• Type 2 diabetes (T2D) red blood cells (RBCs) induce endothelial dysfunction, linked to lower microRNA-210 levels.
• Type 1 diabetes (T1D) RBCs do not cause this dysfunction, suggesting microRNA-210 has a protective role.
• Understanding these differences is crucial for addressing diabetes-related vascular complications.

Purpose of the Study:

• To investigate the differential role of microRNA-210 in RBCs from T1D and T2D patients.
• To elucidate the mechanisms by which RBC microRNA-210 influences endothelial function and vascular health.
• To identify potential therapeutic targets for improving vascular health in diabetes.

Main Methods:

• Compared RBCs from T1D, T2D, and healthy individuals matched for glycated hemoglobin and demographics.
• Measured microRNA-210 levels using quantitative polymerase chain reaction (qPCR).
• Assessed endothelium-dependent relaxation (EDR) in rat aortas and nitric oxide (NO) production in endothelial cells.
• Quantified protein levels of microRNA-210 target PTP1B and oxidative stress marker 4-HNE via immunohistochemistry.

Main Results:

• T1D RBCs maintained endothelium-dependent relaxation and nitric oxide production similar to healthy controls.
• T2D RBCs significantly impaired endothelium-dependent relaxation and nitric oxide production.
• microRNA-210 levels were reduced in T2D RBCs but not in T1D RBCs compared to healthy controls.
• Inhibition of microRNA-210 in T1D RBCs mimicked T2D RBC effects, increasing vascular PTP1B and 4-HNE.
• PTP1B inhibition or antioxidant treatment improved EDR in T2D models.

Conclusions:

• RBC microRNA-210 plays a critical role in regulating endothelial function differently in T1D versus T2D.
• Reduced microRNA-210 in T2D RBCs contributes to endothelial dysfunction by increasing vascular PTP1B and mitochondrial oxidative stress.
• Targeting microRNA-210, PTP1B, or oxidative stress pathways presents a promising strategy for improving vascular health in T2D.